Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting

Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting

Immunotherapy is the most promising therapeutic approach against malignant pleural mesothelioma (MPM). Despite technological progress, the number of targetable antigens or specific antibodies is limited, thus hindering the full potential of recent therapeutic interventions. All possibilities of find...

Full description

Bibliographic Details
Main Authors: Fabio Nicolini, Martine Bocchini, Davide Angeli, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò, Massimiliano Mazza
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
malignant pleural mesothelioma (MPM)
immunotherapy
fully human antibody
tertiary lymphoid structure (TLS)
therapeutic antibody
MPM management
Online Access:https://www.mdpi.com/2072-6694/12/4/915

Internet

https://www.mdpi.com/2072-6694/12/4/915

Similar Items